Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

Jordi Giralt Lopez de Sagredo

doi:10.1007/s11523-017-0544-z

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

Departament de Medicina

Producció científica: Contribució a una revista › Article › Recerca

Idioma original	English
Nombre de pàgines	1
Revista	Targeted Oncology
Volum	13
Número	79
DOIs	https://doi.org/10.1007/s11523-017-0544-z
Estat de la publicació	Publicada - de febr. 2018

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

Accés al document

10.1007/s11523-017-0544-z

Altres arxius i enllaços

http://dx.doi.org/10.1007/s11523-017-0544-z

Com citar-ho

@article{0ea243bf428c46e4aa8ef745ded00bb9,

title = "Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients",

author = "{Giralt Lopez de Sagredo}, Jordi",

year = "2018",

month = feb,

doi = "10.1007/s11523-017-0544-z",

language = "English",

volume = "13",

journal = "Targeted Oncology",

issn = "1776-2596",

publisher = "Springer Paris",

number = "79",

}

TY - JOUR

T1 - Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

AU - Giralt Lopez de Sagredo, Jordi

PY - 2018/2

Y1 - 2018/2

UR - http://dx.doi.org/10.1007/s11523-017-0544-z

U2 - 10.1007/s11523-017-0544-z

DO - 10.1007/s11523-017-0544-z

M3 - Article

SN - 1776-2596

VL - 13

JO - Targeted Oncology

JF - Targeted Oncology

IS - 79

ER -